Delray Beach's Cambridge Chancellor Dr. Terry LaPier Appointed to Catholic University Advisory Boards
Delray Beach resident and Cambridge Chancellor & CEO Dr. Terry LaPier has been appointed to two influential advisory boards at The Catholic University of America in Washington, D.C. Dr. LaPier will serve on the Boards of Visitors for both The Tim and Steph Busch School of Business and the Conway School of Nursing.
Local Leader Joins D.C. University Boards
The appointments place Dr. LaPier among a group of experienced leaders from the fields of business, healthcare, and education. These Boards of Visitors are tasked with volunteering their expertise to advise the leadership of each school. Their contributions aim to support students and strengthen academic programs within the university.
Dual Role at The Catholic University of America
Dr. LaPier's involvement will extend to two distinct, yet vital, academic divisions at The Catholic University of America. The Tim and Steph Busch School of Business focuses on preparing future leaders in commerce and management, while the Conway School of Nursing addresses the critical need for skilled healthcare professionals.
Purpose of Advisory Boards
Boards of Visitors serve a crucial role in bridging academic institutions with real-world industry practices. Members provide guidance on curriculum development, strategic planning, and community engagement, ensuring that the educational offerings remain relevant and impactful. Their commitment helps shape the future of business and healthcare education.
Impact on Education
Dr. LaPier's appointment signifies a commitment to enhancing the educational experience for students at The Catholic University of America. By sharing insights from his leadership at Cambridge, he will contribute to the development of robust programs designed to equip graduates for success in their chosen professions.
Related Topics
Article Ratings
How do you feel about this story?
Taylor Greer
Sign in to follow this author from their profile.


.png)
Discussion (0)
Join the Conversation
No comments yet. Be the first to comment!